Peripartum cardiomyopathy

Minerva Cardioangiologica

Volumn 51, Issue 1, 2003, Pages 41-48

  Ardehali, H ^a   Kasper, E K ^a   Baughman, K L ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Cardiomyopathy, congestive; Pregnancy complications; Puerperal disorders, drug therapy

Indexed keywords

ARGININE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; ENDOTHELIN RECEPTOR ANTAGONIST; IMMUNOSUPPRESSIVE AGENT; RAMIPRIL; SPIRONOLACTONE; WARFARIN;

ANTICOAGULATION; AORTA BALLOON; CARDIOMYOPATHY; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONVALESCENCE; DEVICE; DIET THERAPY; DISEASE COURSE; DRUG EFFECT; DRUG INDICATION; EXERCISE; HEALTH STATUS; HEART DISEASE; HEART FAILURE; HEART TRANSPLANTATION; HEART VENTRICLE FUNCTION; HUMAN; IDIOPATHIC DISEASE; INOTROPISM; LIFESTYLE; LONG TERM CARE; MYOCARDITIS; PERIPARTUM CARDIOMYOPATHY; PREGNANCY; PROGNOSIS; PUERPERIUM; REVIEW; TERATOGENESIS; TREATMENT FAILURE;

ADULT; CARDIOMYOPATHIES; CARDIOVASCULAR AGENTS; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROGNOSIS;

EID: 0038326736     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Hull E, Hafkesbring E. "Toxic" postpartal heart disease. N Orl Med Surg J 1937;89:550-7.
2. Demakis JG, Rahimtoola SH, Sutton GC, Meadows WR, Szanto PB, Tobin JR et al. Natural course of peripartum cardiomyopathy. Circulation 1971;44:1053-61.
3. Pearson GD, Veille JC, Rahimtoola S, Hsia J, Oakley CM, Hosenpud JD et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 2000;283:1183-8.
4. Baughman KL. Peripartum cardiomyopathy. Curr Treat Options Cardiovasc Med 2001;3:469-80.
5. Sanderson JE, Adesanya CO, Anjorin FI, Parry EH. Postpartum cardiac failure-heart failure due to volume overload? Am Heart J 1979;97:613-21.
6. Cenac A, Simonoff M, Moretto P, Djibo A. A low plasma selenium is a risk factor for peripartum cardiomyopathy: a comprehensive study in Sahelian Africa. Int J Cardiol 1992;36:57-9.
7. Mendelson MA, Chandler J. Postpartum cardiomyopathy associated with maternal cocaine abuse. Am J Cardiol 1992;70:1092-4.
8. Lampert MB, Hibbard J, Weinert L, Briller J, Lindheimer M, Lang R. Peripartum heart failure associated with prolonged tocolytic therapy. Am J Obstet Gynecol 1993;168:493-5.
9. Homans DC. Peripartum cardiomyopathy. N Engl J Med 1985;312:1432-7.
10. Melvin KR, Richardson PJ, Olsen EG, Daly K, Jackson G. Peripartum cardiomyopathy due to myocarditis. N Engl J Med 1982;307:731-4.
11. Sanderson JE, Olsen EG, Gatei D. Peripartum heart disease: an endomyocardial biopsy study. Br Heart J 1986;56:285-91.
12. Midei MG, DeMent SH, Feldman AM, Hutchins GM, Baughman KL. Peripartum myocarditis and cardiomyopathy. Circulation 1990;81:922-8.
13. Rizeq MN, Rickenbacher PR, Fowler MB, Billingham ME. Incidence of myocarditis in peripartum cardiomyopathy. Am J Cardiol 1994;74:474-7.
14. Felker GM, Jaeger CJ, Klodas E, Thiemann DR, Hare JM, Hruban RH et al. Myocarditis and long-term survival in peripartum cardiomyopathy. Am Heart J 2000;140: 785-91.
15. Cenac A, Gaultier Y, Devillechabrolle A, Moulias R. Enterovirus infection in peripartum cardiomyopathy. Lancet 1988;2:968-9.
16. Coulson CC, Thorp JM, Mayer DC, Cefalo RC. Central hemodynamic effects of recombinant human relaxin in the isolated, perfused rat heart model. Obstet Gynecol 1996;87:610-2.
17. Sliwa K, Skudicky D, Bergemann A, Candy G, Puren A, Sareli P. Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1. J Am Coll Cardiol 2000;35: 701-5.
18. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ, Cuddy TE et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 1992;327:669-77.
19. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342: 821-8.
20. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685-91.
21. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316: 1429-35.
22. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303-10.
23. Begg EJ, Robson RA, Gardiner SJ, Hudson LJ, Reece PA, Olson SC et al. Quinapril and its metabolite quinaprilat in human milk. Br J Clin Pharmacol 2001;51:478-81.
24. Waagstein F, Hjalmarson A, Varnauskas E, Wallentin I. Effect of chronic β-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 1975;37: 1022-36.
25. Foody JM, Farrell MH, Krumholz HM. β-blocker therapy in heart failure: scientific review. JAMA 2002; 287:883-9.
26. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344: 1651-8.
27. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldmanmd AM, Francis GS et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1995 guidelines for the evaluation and management of heart failure): developed in collaboration with the International Society for Heart and Lung Transplantation; endorsed by the Heart Failure Society of America. Circulation 2001;104: 2996-3007.
28. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A et al. Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709-17.
29. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997;336:525-33.
30. Baughman KL. The heart and pregnancy. In: Topol EJ, editors. Textbook of cardiovascular medicine. Philadelphia, PA: Lippincott-Raven; 1998.p.797-816.
31. Bozkurt B, Villaneuva FS, Holubkov R, Tokarczyk T, Alvarez RJ, MacGowan GA et al. Intravenous immune globulin in the therapy of peripartum cardiomyopathy. J Am Coll Cardiol 1999;34:177-80.
32. Kjaer A, Hesse B. Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives. Clin Physiol 2001;21:661-72.
33. Colucci WS, Elkayam U, Horton DP, Abraham WT, Bourge RC, Johnson AD et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. N Engl J Med 2000;343: 246-53.
34. Lewis R, Mabie WC, Burlew B. Biventricular assist device as a bridge to cardiac transplantation in the treatment of peripartum cardiomyopathy. South Med J 1997;90:955-8.
35. Tandler R, Schmid C, Weynard M, Scheld HH. Novacor LVAD bridge to transplantation in peripartum cardiomyopathy. Eur J Cardiothorac Surg 1997;11:394-6.
36. Johnson MR, Naftel DC, Hobbs RE, Kobashigawa JA, Pitts DE, Levine TB et al. Cardiac Transplant Research Database Group. The incremental risk of female sex in heart transplantation: a multiinstitutional study of peripartum cardiomyopathy and pregnancy. J Heart Lung Transplant 1997;16:801-12.
37. Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000;342: 1077-84.
38. Elkayam U, Tummala PP, Rao K, Akhter MW, Karaalp IS, Wani OR et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 2001;344:1567-71.
39. Lampert MB, Winert L, Hibbard J, Korcarz C, Lindheimer M, Lang RM. Contractile reserve in patients with peripartum cardiomyopathy and recovered left ventricular function. Am J Obstet Gynocol 1997;176:189-95.